Class II transactivator regulates the expression of multiple genes involved in antigen presentation.
about
The histone acetyltransferase domains of CREB-binding protein (CBP) and p300/CBP-associated factor are not necessary for cooperativity with the class II transactivatorPositive regulatory domain I-binding factor 1 mediates repression of the MHC class II transactivator (CIITA) type IV promoterThe class II trans-activator CIITA interacts with the TBP-associated factor TAFII32CIITA leucine-rich repeats control nuclear localization, in vivo recruitment to the major histocompatibility complex (MHC) class II enhanceosome, and MHC class II gene transactivationClass II transactivator: mastering the art of major histocompatibility complex expressionBasophils function as antigen-presenting cells for an allergen-induced T helper type 2 responseMitogen-activated protein kinase ERK1/2 regulates the class II transactivatorHepatitis C Virus Inhibits Cell Surface Expression of HLA-DR, Prevents Dendritic Cell Maturation, and Induces Interleukin-10 ProductionThe RFX family interacts at the collagen (COL1A2) start site and represses transcriptionMHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarctionFailure of MHC class II expression in neonatal alveolar macrophages: potential role of class II transactivatorIdentification of a transcription factor that binds to the S box of the I-A beta gene of the major histocompatibility complexNegative regulation by HLA-DO of MHC class II-restricted antigen processingSingle cell analysis reveals regulated hierarchical T cell antigen receptor signaling thresholds and intraclonal heterogeneity for individual cytokine responses of CD4+ T cellsCostimulatory ligand CD70 is delivered to the immunological synapse by shared intracellular trafficking with MHC class II molecules.Tumor necrosis factor-alpha and the progression of diabetes in non-obese diabetic mice.Cell-based vaccines for the stimulation of immunity to metastatic cancers.Modulation of major histocompatibility class II protein expression by varicella-zoster virusCIITA variation in the presence of HLA-DRB1*1501 increases risk for multiple sclerosis.Involvement of clathrin and AP-2 in the trafficking of MHC class II molecules to antigen-processing compartmentsPromoter-specific functions of CIITA and the MHC class II enhanceosome in transcriptional activationRegulation of antigen presentation by Mycobacterium tuberculosis: a role for Toll-like receptorsEpstein-Barr virus evades CD4+ T cell responses in lytic cycle through BZLF1-mediated downregulation of CD74 and the cooperation of vBcl-2.The epithelial cell cytoskeleton and intracellular trafficking. V. Polarized compartmentalization of antigen processing and Toll-like receptor signaling in intestinal epithelial cells.Sepsis induces specific changes in histone modification patterns in human monocytes.Statins and their potential targets in multiple sclerosis therapy.Targeted therapy of solid malignancies via HLA class II antigens: a new biotherapeutic approach?Multiple Sclerosis Risk Allele in CLEC16A Acts as an Expression Quantitative Trait Locus for CLEC16A and SOCS1 in CD4+ T Cells.Deficient antigen-presenting cell function in multiple genetic complementation groups of type II bare lymphocyte syndrome.Pathogenesis of intracranial aneurysm is mediated by proinflammatory cytokine TNFA and IFNG and through stochastic regulation of IL10 and TGFB1 by comorbid factors.Importance of acidic, proline/serine/threonine-rich, and GTP-binding regions in the major histocompatibility complex class II transactivator: generation of transdominant-negative mutants.The rs4774 CIITA missense variant is associated with risk of systemic lupus erythematosus.HLA-DRB1 and HLA-DQB1 methylation changes promote the occurrence and progression of Kazakh ESCC.Autoimmune arthritis associated with mutated interleukin (IL)-6 receptor gp130 is driven by STAT3/IL-7-dependent homeostatic proliferation of CD4+ T cells.Thymic selection pathway regulates the effector function of CD4 T cells.Major histocompatibility complex class II-transfected tumor cells present endogenous antigen and are potent inducers of tumor-specific immunity.Selective binding of bacterial toxins to major histocompatibility complex class II-expressing cells is controlled by invariant chain and HLA-DM.CIITA is not associated with risk of developing rheumatoid arthritisA novel antigen-processing-defective phenotype in major histocompatibility complex class II-positive CIITA transfectants is corrected by interferon-gamma.Neonatal tumor necrosis factor alpha promotes diabetes in nonobese diabetic mice by CD154-independent antigen presentation to CD8(+) T cells.
P2860
Q22330805-CA126279-6474-4957-AD4F-E2A161623B99Q24289417-F1925143-B437-4CD8-8490-EE1E038D3E7DQ24336213-D3C8576B-87E6-45B6-A2D8-BE723756C63AQ24551176-9C3EF061-5490-49D7-864B-F54E9C963714Q24552298-3A670EED-CA93-4586-9E93-27A59772C516Q24613860-BA89CC99-AFC3-4873-A103-B4078FE485DAQ24652921-B43AD9F7-D084-4304-BD8C-9505B7E0CA16Q27485530-8DAE921F-459A-43DE-B2DB-2B6DE4427DE8Q28216325-66E19800-5B3E-41FD-BC6A-FA16D8E4F626Q28581447-6CD4699F-93AC-4DF4-B991-CFD60ECB5A70Q28582149-3D7F51A2-E6AE-4DB8-BD4D-031A53410243Q28585203-DDEF3DFE-14B8-49DF-AC1F-A401784B31FDQ28613199-FB1E4F9A-754E-4971-B678-06A0304FC0A3Q28755947-18589967-378F-42B0-8D88-E4E59952A6E8Q30479269-BE252490-A4B5-45EC-8608-9D494E9160A0Q33713257-91ED209A-FC8A-44E0-B1E8-9D9DB5AF4FA1Q33776134-EDF0D7D6-F13B-4074-8BCB-BEB926C579DEQ33797830-6F794800-88D0-4BC2-BB77-B67A5E262299Q33832877-9BBE6E2E-5DDB-41A6-8807-A99A4B1EED1CQ33833534-770B6DE6-80F9-4FD0-ADB2-F604221AEC11Q34086182-FFF3DE3F-644D-48E1-899C-32ED6CCA3457Q34104329-6D87C08C-0389-45DC-8F5D-754E2701A1D5Q34116845-3664988A-A7DA-4DCC-826D-983363B39506Q34838371-AD3E9584-AEE5-492B-8C76-BDE8977B9235Q35202893-A17D2C54-AA47-4BA8-BC9C-84967F1093F1Q35537898-42B4950A-ED3A-4471-A200-8E832E03A4FDQ35551133-AA2D29C1-DFE3-4581-983F-AF0F9E3B6FCDQ35708039-ADEBA917-2BC7-488D-83BD-FE538068D60FQ35750316-B7AF66E5-4AB7-4ECF-B54E-87251C799915Q35878230-01AA2DC0-6EFF-4F30-A67C-9CE2CC881769Q36048657-5A4888BA-CC9A-4ECD-855C-7EBAF965CD7AQ36070941-035E0298-2359-410F-AF13-9844F4AC4E7AQ36215782-B4B05053-5B2C-4877-A416-C9D555C94B7AQ36228672-D415C446-E9CC-411F-843C-425F2A0CC991Q36229651-02837D00-7B23-46A7-98C4-D96D322BCDDEQ36241838-9F022010-D120-4B68-9D9E-B3584866DE2CQ36241909-83B3D17F-0411-4F63-B457-2AD6206153D7Q36253879-80CDC43D-B184-43A7-9161-0BF1CA8E39FEQ36365569-47CF77A0-085D-4F9F-AF9D-DE6D20DD5D31Q36375728-A0C32BBA-B47B-43FC-B284-F09039D5052C
P2860
Class II transactivator regulates the expression of multiple genes involved in antigen presentation.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Class II transactivator regula ...... olved in antigen presentation.
@en
type
label
Class II transactivator regula ...... olved in antigen presentation.
@en
prefLabel
Class II transactivator regula ...... olved in antigen presentation.
@en
P2860
P356
P1476
Class II transactivator regula ...... olved in antigen presentation.
@en
P2093
R A Flavell
P2860
P304
P356
10.1084/JEM.181.2.765
P407
P577
1995-02-01T00:00:00Z